Evidence map›Paper›PMID 42782905›Full record

ArticleCurrent oncology (Toronto, Ont.)2026

Simon Guertin, Niloofar Sina, Ken Kron, Kenneth J Craddock, Amy McCarty, David M Hwang, Weei-Yuarn Huang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Simon GuertinDepartment of Clinical Pathology, Quebec University Hospital Center, Laval University, Quebec, QC G1R 2J6, Canada.
Niloofar SinaLaboratory Medicine Program, Department of Anatomic al Pathology, University Health Network, University of Toronto, 200 Elizabeth St, Toronto, ON M5G 2C4, Canada.
Ken KronDepartment of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, North York, Toronto, ON M4N 3M5, Canada.
Kenneth J CraddockDepartment of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, North York, Toronto, ON M4N 3M5, Canada.ORCID 0000-0001-9702-0830
Amy McCartyDepartment of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, North York, Toronto, ON M4N 3M5, Canada.
David M HwangDepartment of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, North York, Toronto, ON M4N 3M5, Canada.
Weei-Yuarn HuangDepartment of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, North York, Toronto, ON M4N 3M5, Canada.ORCID 0009-0001-3604-9645

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibroblast growth factor receptor 2 (FGFR2) fusions are identified in approximately 10-16% of patients with intrahepatic cholangiocarcinoma (iCCA) and represent actionable targets, with several FGFR inhibitors approved for clinical use. To evaluate the clinical utility and assay performance of an amplicon-based next-generation sequencing (NGS) approach in this setting, we assessed

Indexed as

Bile Duct NeoplasmsCholangiocarcinomaHigh-Throughput Nucleotide SequencingPancreatic NeoplasmsReceptor, Fibroblast Growth Factor, Type 2FemaleHumansMaleParaffin EmbeddingRetrospective StudiesFGFR2 protein, humanReceptor, Fibroblast Growth Factor, Type 2amplicon-based NGSFFPE specimensFGFR2 fusionintrahepatic cholangiocarcinomalow input RNAprecision oncologyRNA fusion testing

Identifiers

PMID42782905
PMCPMC13605137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.